Characterization of Exosomes From Semen of Uninfected and HIV-Infected Men

未感染和 HIV 感染男性精液中外泌体的表征

基本信息

  • 批准号:
    9062790
  • 负责人:
  • 金额:
    $ 25.23万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-03-01 至 2018-02-28
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): The continuing spread of HIV/AIDS in people is predominantly fueled by sexual exposure to HIV-contaminated semen/seminal plasma (SP). SP harbors a variety of pro-inflammatory factors that may facilitate HIV transmission by promoting the production of cytokines/chemokines that recruit permissive cells, enhance the translocation of HIV across the genital epithelium, and activate HIV gene transcription. The levels of these factors have been shown to be altered during HIV infection, with HIV-infected individuals generally harboring higher levels of various pro-inflammatory cytokines in SP. We and others have extensively studied the properties of SP constituents, both with regards to their ability to promote HIV infection and their ability to create an inflammatory state favoring HIV replication. However, one class of factors in SP that has received little attention is exosomes, small extracellular vesicles of which trillions are typically present in a single ejaculate. Exosomes are important intercellular signal transducers and induce various inflammatory or immunomodulatory responses. Although numerous studies have characterized plasma-derived exosomes from both uninfected and HIV-infected individuals, very little has been done to understand the relationship between semen exosomes and HIV transmission. In this R21, we test the hypotheses that HIV infection alters the composition of exosomes in SP and that SP exosomes from HIV-infected men can induce inflammation and promote susceptibility to HIV infection. We will accomplish this by assessing in Aim 1 how HIV infection and ART treatment status affect the quantity, composition, and RNA cargo of exosomes in SP. Then in Aim 2, we will directly test the whether exosomes from HIV-infected men contribute towards the ability of SP to induce inflammation in cells lining the genital mucosa, and whether these exosomes can increase the susceptibility of permissive cells to HIV infection. These studies will be the first t characterize SP exosomes from HIV-infected men, and will lead to a better understanding of how these vesicles affect the early events of sexual transmission of HIV.
 描述(由申请人提供):艾滋病毒/艾滋病在人群中的持续传播主要是由于性接触艾滋病毒污染的精液/精浆(SP)。SP含有多种促炎因子,这些促炎因子可通过促进细胞因子/趋化因子的产生来促进HIV传播,所述细胞因子/趋化因子募集容许细胞,增强HIV穿过生殖器上皮的易位,并激活HIV基因转录。这些因素的水平已被证明是在HIV感染过程中改变,与HIV感染的个体一般窝藏在SP的各种促炎细胞因子的水平较高。我们和其他人已经广泛研究了SP成分的属性,无论是关于他们的能力,以促进HIV感染和他们的能力,创造一个炎症状态有利于HIV复制。然而,SP中的一类因子很少受到关注,是外泌体,一种小的细胞外囊泡,其中数万亿通常存在于单个射精中。外来体是 重要的细胞间信号转导和诱导各种炎症或免疫调节反应。尽管许多研究已经表征了来自未感染和HIV感染个体的血浆来源的外泌体,但很少有人了解精液外泌体与HIV传播之间的关系。在这个R21中,我们测试了HIV感染改变SP外泌体组成的假设,以及来自HIV感染男性的SP外泌体可以诱导炎症并促进对HIV感染的易感性。我们将通过在目标1中评估HIV感染和ART治疗状态如何影响SP中外来体的数量、组成和RNA货物来实现这一点。然后在目标2中,我们将直接测试来自HIV感染男性的外来体是否有助于SP诱导生殖器粘膜内衬细胞中炎症的能力,以及这些外来体是否可以增加允许细胞对HIV感染的易感性。这些研究将是第一个表征来自HIV感染男性的SP外泌体的研究,并将有助于更好地了解这些囊泡如何影响HIV性传播的早期事件。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nadia R Roan其他文献

Transient Anti-Interferon Auto Antibodies in the Airway Are Associated with Recovery in Mild COVID-19
  • DOI:
    10.1182/blood-2023-190358
  • 发表时间:
    2023-11-02
  • 期刊:
  • 影响因子:
  • 作者:
    Benjamin R Babcock;Astrid Kosters;Nadia R Roan;Sulggi Lee;Eliver E.B. Ghosn
  • 通讯作者:
    Eliver E.B. Ghosn

Nadia R Roan的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Nadia R Roan', 18)}}的其他基金

Reservoir features associated with time-to-rebound during analytical treatment interruption
与分析处理中断期间的反弹时间相关的储层特征
  • 批准号:
    10459934
  • 财政年份:
    2022
  • 资助金额:
    $ 25.23万
  • 项目类别:
Characterizing ART-free NK cell-mediated control of HIV infection in people living with HIV
描述 HIV 感染者中无 ART 的 NK 细胞介导的 HIV 感染控制
  • 批准号:
    10535192
  • 财政年份:
    2022
  • 资助金额:
    $ 25.23万
  • 项目类别:
Characterizing ART-free NK cell-mediated control of HIV infection in people living with HIV
描述 HIV 感染者中无 ART 的 NK 细胞介导的 HIV 感染控制
  • 批准号:
    10671559
  • 财政年份:
    2022
  • 资助金额:
    $ 25.23万
  • 项目类别:
Reservoir features associated with time-to-rebound during analytical treatment interruption
与分析处理中断期间的反弹时间相关的储层特征
  • 批准号:
    10614027
  • 财政年份:
    2022
  • 资助金额:
    $ 25.23万
  • 项目类别:
Phenotypic and mechanistic analysis of the in vivo HIV latent reservoir by single-cell technologies
通过单细胞技术对体内 HIV 潜伏病毒库进行表型和机制分析
  • 批准号:
    10357547
  • 财政年份:
    2019
  • 资助金额:
    $ 25.23万
  • 项目类别:
Phenotypic and mechanistic analysis of the in vivo HIV latent reservoir by single-cell technologies
通过单细胞技术对体内 HIV 潜伏病毒库进行表型和机制分析
  • 批准号:
    10448398
  • 财政年份:
    2019
  • 资助金额:
    $ 25.23万
  • 项目类别:
Phenotypic and mechanistic analysis of the in vivo HIV latent reservoir by single-cell technologies
通过单细胞技术对体内 HIV 潜伏病毒库进行表型和机制分析
  • 批准号:
    10360854
  • 财政年份:
    2019
  • 资助金额:
    $ 25.23万
  • 项目类别:
Project 1: Using CyTOF to identify phenotypic and functional biomarkers predicting time to HIV rebound after treatment interruption
项目 1:使用 CyTOF 识别表型和功能生物标志物,预测治疗中断后 HIV 反弹的时间
  • 批准号:
    10223995
  • 财政年份:
    2017
  • 资助金额:
    $ 25.23万
  • 项目类别:
Exploiting the Host-HIV Interface To Identify Biomarkers Predicting Time to Viral Rebound after Treatment Interruption
利用宿主-HIV 界面识别生物标志物,预测治疗中断后病毒反弹的时间
  • 批准号:
    10223991
  • 财政年份:
    2017
  • 资助金额:
    $ 25.23万
  • 项目类别:
Characterization of Exosomes From Semen of Uninfected and HIV-Infected Men
未感染和 HIV 感染男性精液中外泌体的表征
  • 批准号:
    9228315
  • 财政年份:
    2016
  • 资助金额:
    $ 25.23万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.23万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 25.23万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.23万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.23万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 25.23万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.23万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.23万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.23万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 25.23万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 25.23万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了